Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Of 40 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), 28 completed a controlled three‐month trial of prednisone. Prednisone was shown to cause a small but significant improvement over no treatment in scored neurological disability, some measures of computer‐assisted sensory detection threshold, graded muscle strength, and some attributes of nerve conduction. No subset of patients was more likely than another to be responsive to prednisone; those with a progressive course were as likely to be responsive as recurrent cases. This finding provides further justification for classifying progressive with recurrent cases as CIDP and demonstrates that prednisone treatment should not be withheld from patients with progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Inflammatory Polyradiculoneuropathy
Millichap, J. G. (1997) · Pediatric Neurology Briefs · doi:10.15844/pedneurbriefs-11-12-6 · Cited by 822
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometry
Dyck, P. J., Sherman, W. R., Hallcher, L. M., John Service, F., O'Brien, P. C., Grina, L. A., Palumbo, P. J., & Swanson, C. J. (1980) · Annals of Neurology · doi:10.1002/ana.410080608 · Cited by 511
Self-citationIntensive evaluation of referred unclassified neuropathies yields improved diagnosis
Dyck, P. J., Oviatt, K. F., & Lambert, E. H. (1981) · Annals of Neurology · doi:10.1002/ana.410100304 · Cited by 324
Self-citationChronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment
Dalakas, M. C., & Engel, W. K. (1981) · Annals of Neurology · doi:10.1002/ana.410090719 · Cited by 291
Criteria for the diagnosis of the Guillain-Barré syndrome
Poser, C. M. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90004-6 · Cited by 264
Dyck, P. J., Zimmerman, I. R., O' Brien, P. C., Ness, A., Caskey, P. E., Karnes, J., & Bushek, W. (1978) · Annals of Neurology · doi:10.1002/ana.410040605 · Cited by 203
Self-citationDyck, P. J., Gutrecht, J. A., Bastron, J. A., Karnes, W. E., & Dale, A. J. D. (1968) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(26)01576-4 · Cited by 173
Self-citationLAMPERT, P. W. (1965) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196507000-00001 · Cited by 165
PURE PAN-DYSAUTONOMIA WITH RECOVERY: DESCRIPTION AND DISCUSSION OF DIAGNOSTIC CRITERIA
YOUNG, R. R., ASBURY, A. K., CORBETT, J. L., & ADAMS, R. D. (1975) · Brain · doi:10.1093/brain/98.4.613 · Cited by 161
Cited by
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
Stuck, A. E., Minder, C. E., & Frey, F. J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.6.954 · Cited by 836
Hughes, R., Bensa, S., Willison, H., Van Den Bergh, P., Comi, G., Illa, I., Nobile‐Orazio, E., Van Doorn, P., Dalakas, M., Bojar, M., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1088 · Cited by 628
Barohn, R. J. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440064022 · Cited by 567
Joint Task Force of the EFNS and the PNS (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00245.x · Cited by 539
Van den Bergh, P. Y. K., van Doorn, P. A., Hadden, R. D. M., Avau, B., Vankrunkelsven, P., Allen, J. A., Attarian, S., Blomkwist‐Markens, P. H., Cornblath, D. R., Eftimov, F., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14959 · Cited by 530
Van den Bergh, P. Y. K., van Doorn, P. A., Hadden, R. D. M., Avau, B., Vankrunkelsven, P., Allen, J. A., Attarian, S., Blomkwist‐Markens, P. H., Cornblath, D. R., Eftimov, F., et al. (2021) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12455 · Cited by 520
Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Dyck, P. J., Daube, J., O'Brien, P., Pineda, A., Low, P. A., Windebank, A. J., & Swanson, C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140801 · Cited by 489
Self-citationDyck, P. J., Litchy, W. J., Kratz, K. M., Suarez, G. A., Low, P. A., Pineda, A. A., Windebank, A. J., Karnes, J. L., & O'Brien, P. C. (1994) · Annals of Neurology · doi:10.1002/ana.410360607 · Cited by 471
Self-citationMCOMBE, P. A., POLLARD, J. D., & MCLEOD, J. G. (1987) · Brain · doi:10.1093/brain/110.6.1617 · Cited by 458
Total neuropathy score: Validation and reliability study
Cornblath, D. R., Chaudhry, V., Carter, K., Lee, D., Seysedadr, M., Miernicki, M., & Joh, T. (1999) · Neurology · doi:10.1212/wnl.53.8.1660 · Cited by 449
Hahn, A. F., Bolton, C. F., Zochodne, D., & Feasby, T. E. (1996) · Brain · doi:10.1093/brain/119.4.1067 · Cited by 439
Clinical spectrum of chronic acquired demyelinating polyneuropathies
Saperstein, D. S., Katz, J. S., Amato, A. A., & Barohn, R. J. (2001) · Muscle & Nerve · doi:10.1002/1097-4598(200103)24:3<311::aid-mus1001>3.0.co;2-a · Cited by 417
Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features
Albers, J. W., & Kelly, J. J. (1989) · Muscle & Nerve · doi:10.1002/mus.880120602 · Cited by 346
Advances in the diagnosis, pathogenesis and treatment of CIDP
Dalakas, M. C. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.121 · Cited by 296
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England
Lunn, M. P. T., Manji, H., Choudhary, P. P., Hughes, R. A. C., & Thomas, P. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.5.677 · Cited by 276
Multifocal motor neuropathy improved by IVIg: Randomized, double-blind, placebo-controlled study
Federico, P., Zochodne, D. W., Hahn, A. F., Brown, W. F., & Feasby, T. E. (2000) · Neurology · doi:10.1212/wnl.55.9.1256 · Cited by 263
Vermeulen, M., van Doorn, P. A., Brand, A., Strengers, P. F., Jennekens, F. G., & Busch, H. F. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.1.36 · Cited by 223
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
Vermeulen, M., van der Meché, F. G. A., Speelman, J. D., Weber, A., & Busch, H. F. M. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90173-x · Cited by 178
Hypothalamic involvement in Huntington's disease: an in vivo PET study
Politis, M., Pavese, N., Tai, Y. F., Tabrizi, S. J., Barker, R. A., & Piccini, P. (2008) · Brain · doi:10.1093/brain/awn244 · Cited by 174
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Eftimov, F., Winer, J. B., Vermeulen, M., de Haan, R., & van Schaik, I. N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001797.pub3 · Cited by 165
van Doom, P. A. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530140113024 · Cited by 165
van der Mech�, F. G. A., & van Doorn, P. A. (1995) · Annals of Neurology · doi:10.1002/ana.410370704 · Cited by 131
Metadata
- Authors
- Dyck, P. J., O'Brien, P. C., Oviatt, K. F., Dinapoli, R. P., Daube, J. R., Bartleson, J. D., Mokri, B., Swift, T., Low, P. A., & Windebank, A. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1982-02
- Volume
- 11
- Issue
- 2
- Pages
- 136-141
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2154028856
- Cited by
- 483
- References
- 13
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.